RP1 Experimental Neurobiology

Research of Neurobiology of Ageing, Addictions and Serious Mental Disorders (NESTAR)


Head of the department
Prof. Saak Victor Ovsepian, M.D., Ph.D.
Contact
Ing. J. Jechová / Bc. K. Tomková (coordinator, RP1 assistant)
telephone:(+420) 283 088 243  /  +42 028 308 824 5
e-mail:jitka.jechova@nudz.cz / katerina.tomkova@nudz.cz


Profile

The Department of Experimental Neurobiology (or Research Programme 1, RP1) is an integral part of the National Institute of Mental Health, Czech Republic. It is a modern, multidisciplinary and international research organisation, which amalgamates six large groups comprised of senior and junior investigators, postgraduate and undergraduate students alongside an efficient team of administrative support. The department maintains a highly dynamic and inquisitive environment and fosters a spirit of excellence and collaborative research between biologists, psychologists, physicists, biochemists, neuroscientists, programmers and medical doctors.

It comprises state-of-the-art laboratories equipped with cutting-edge instrumentation and tools compatible with a wide range of biomedical research. Given the aim of elucidating the molecular and cellular bases of brain aging, neurodegenerative and psychiatric disease, the portfolio of RP1 includes research facilities for cellular and molecular biology, biochemistry, neurophysiological and pharmacological research, as well as behavioural studies. It also contains modern histology and immunohistochemistry units equipped with top of the range epifluorescence and confocal imaging systems, as well as modern tissue culture and viral research laboratories.

Investigation involving experimental animal models of Alzheimer’s disease, autism, schizophrenia and a range of other neuropsychiatric diseases is a major part of ongoing projects, supported by a modern bio-resources unit, where animal models are generated and maintained. The functional neurophysiological read-outs from single neurones and population activity profiles from neuronal networks are routinely acquired in animals representing different physiological contexts and behavioural states. Combined with optogenetic stimulation and calcium imaging, which are currently under development in RP1, these measurements enable the elucidation of changes in brain activity affected by neurological and psychiatric disease. In parallel, behavioural tests such as the Morris water maze, fear conditioning and open field arenas are applied for real-time monitoring of animal behaviour relative to altered neuronal processes.

The specific nature and interdisciplinary stance of neurobiological research applied here involves the coordinated efforts of a large team of researchers and managers, to improve the understanding and treatment of brain and mind disorders, and to facilitate public awareness and acceptance of issues related to psychiatric disease. As a vibrant and progressive research organisation, RP1 promotes quality and creativity, to enhance discovery alongside medical translation, bolstered by its strong commitment to teaching and collaborations on both a national and international scale. 

Neuropsychiatric research is going through very exciting times and the Department of Experimental Neurobiology is an inspiring place to be. We are looking for talented researchers and neuroscience enthusiasts to join our strong team, to make an impact and bring knowledge plus understanding to the pain and suffering inflicted by neuropsychiatric and neurodegenerative disease. For all enquiries related to research and collaboration possibilities, please contact Ms. Jechova (jitka.jechova@nudz.cz).  

RP1 administration

 

NEWS AND MEDIA

The Head of Animal Models of Neurodevelopmental and Psychiatric Diseases Group Dr. Petrasek Receives the Prize „Dr. Bures“ at the IX Neuropsychiatric Forum in Prague, April 24 – 26, 2019 (http://npforum.eu/).

A Member of Animal Models of Neurodevelopmental and Psychiatric Diseases Mgr. Iveta Vojtěchová Receives the Best Poster Award for the Project Entitled „Maternal Immune Activation in the Rat: Do We Model Schizophrenia or Autism?“ at the IX Neuropsychiatric Forum in Pargue, , April 24 – 26, 2019 (http://npforum.eu/).

The British Journal of Psychiatry selects the ‚Dark Matter of the Brain‘ article by Prof. Saak V. Ovsepian published in the Brain Structure and Function as one of the most preeminent recent developments in the field (https://www.cambridge.org/core/services/aop-cambridge-core/content/view/47F6B87901A64F69F7D6B1953F1F7260/S0007125019000503a.pdf/kaleidoscope.pdf)

The Annual Molecular and Cellular Neuroimaging Workshop-2019 (March-April) organized by the Department of Experimental Neurobiology at the National Institute of Mental Health. Participant institutes (1) National Institute of Mental Health, Klecany, (2) Institute of Physiology, National Academy of Sciences, Prague, (3) 3rd Faculty of Medicine Charles University, Prague and (4) Department of Biophysical Chemistry, J. Heyrovsky Institute of Physical Chemistry, National Academy of Sciences, Prague. Support of the project: RVO by the Ministry of Health, Czech Republic (https://www.nudz.cz/eduEventDetail/?id=277).

'Invisible Neurons, Relict Networks and Dark Matter of the Brain. A New Hypothesis on Silent Neurons and Brains Dark Matter' proposed by Prof. Saak V. Ovsepian in the Spotlight of LINK.MEDIUM.COM (https://medium.com/dialogue-and-discourse/the-invisible-brain-6deab6f3d41d).

'Who We are and What We Do?' A Note from the Department of Experimental Neurobiology at the National Institute of the Mental Health, Czech Republic (https://www.researchgate.net/publication/330925540_RP1-_NUDZ_LETTER_2019) Published in NUDZ Letters 2/2019 (in Czech).

A recent study from NUDZ published in Brain Structure and Function by Prof. Ovsepian is in the Spotlight of the Science Trends: 'The Dark Matter of the Brain Lights up' (https://sciencetrends.com/the-dark-matter-of-the-brain-lights-up/)

ČNPS Prize for the Best Poster in the Field of Psychopharmaceutical Research to Dr. Štefková (Dr. Páleníček group) at 61st Czech-Slovak Psychopharmacological Conference in Jeseník 2019. Title of the related paper 'Effect of Openclomethamine and its Enantiomers on Behavior and Pharmacokinetic Profile in Wistar Rats'.

Dr. Hana Georgi and her work group were awarded for the Best Contribution on Neurodegenerative Diseases by the Alzheimer Endowment Fund at 61st Czech-Slovak Psychopharmacological Conference in Jeseník 2019. Subject: 'Cognitive Calculator. KoKa 2.0 Software'.

The Prestigious Alzheimer Endowment Fund Award 2018 goes to RP1 researcher M.Sc. Dagmar Bezdekova (Dr. Kristofikova group) for the Best Poster on 'Cellular Models of Tauopathy in Alzheimer's Disease Studies' at 4th Interdisciplinary Student Scientific Conference on Aging (http://www.nudz.cz/_intra-net_/Aktuality/)

'A Study of the Obsessive-Compulsive Disease in Animal Models' by Dr. Eva Szczurowska (Dr. Kelemen group) receives the Annual Prize for the Best Research Presentation in 2018 from the National Institute of Mental Health, Czech Republic (http://www.nudz.cz/_intra-net_/Aktuality/)

'New Research of the Effects of Psychedelics on EEG Spectra and Temporal Synchrony' by Mr. Vejmola (Dr. Palenicek group) receives Prof. Dr. med. Werer M. Herrmann (1941-2002) Memorial Grant at the IPEG Congress in Zurich, 2018 (http://www.nudz.cz/_intra-net_/Aktuality/)

Science Trends: 'When Brain Bleeds Glutamate: A New Perspective On Alzheimer’s Disease' (https://sciencetrends.com/when-brain-bleeds-glutamate-a-new-perspective-on-alzheimers-disease/)

The Irish Times: 'Searching for Alzheimer Clues Inside the Brain's Cells as well as out' (https://www.irishtimes.com/life-and-style/health-family/searching-for-alzheimer-clues-inside-the-brains-cells-as-well-as-out-1.3610180)

Science Trends: 'Pain Relief with Interference shRNA Proves Viable' (https://sciencetrends.com/pain-relief-interference-shrna-proves-viable/)

The Department of Experimental Neurobiology at the National Institute of the Mental Health Gets a New Leader: https://www.researchgate.net/publication/329701477_SAAK_OVSEPIAN-NUDZ

 

SELECTED PUBLICATIONS 2018 - 2019

O'LEARY, VB., OVSEPIAN, SV., SMIDA, J., ATKINSON, MJ. PARTICLE − The RNA podium for genomic silencers. The Journal of Cellular Physiology. 2019, Volume 234(8), 1-7. ISSN 0021-9541. DOI: 10.1002/jcp.28739. IF 4.080.

OLEFIR, I., GHAZARYAN, A., YANG, H., MALEKZADEH-NAJAFABADI, J., GLASL, S., SYMVOULIDIS, P., O’LEARY, VB., SERGIADIS, G., NTZIACHRISTOS, V., OVSEPIAN, SV. Spatial and Spectral Mapping and Decomposition of Neural Dynamics and Organization of the Mouse Brain with Multispectral Optoacoustic Tomography. Cell Reports. 2019, 2019(26), 2833-2846. ISSN 2211-1247. DOI: https://www.cell.com/cell-reports/pdf/S2211-1247(19)30182-2.pdf. IF 8.032.

OVSEPIAN, S.V., The dark matter of the brain. Brain Struct Funct. 2019, 429(1835). doi: https://doi.org/10.1007/s00429-019-01835-7. IF 4.231.

KRAJČOVIČ B., FAJNEROVÁ I., HORÁČEK J., KELEMEN E., KUBÍK Š., SVOBODA J., STUCHLÍK A. Neural and neuronal discoordination in schizophrenia: From ensembles through networks to symptoms. Acta Physiologica (Oxf). 2019 Apr 19:e13282. doi: 10.1111/apha.13282. [Epub ahead of print] Review. IF 5.9.

OVSEPIAN, S.V., O'LEARY, V.B. Can arginase inhibitors be the answer to therapeutic challenges in Alzheimer's disease? Neurotherapeutics. 2018 Sep 21. doi: 10.1007/s13311-018-0668-6. IF 6.032

SZCZUROWSKA, E., AHUJA, N., JIRUŠKA, P., KELEMEN, E., STUCHLÍK, A. Impairment of neural coordination in hippocampal neuronal ensembles after a psychotomimetic dose of dizocilpine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2018, 81(February), 275-283. ISSN 0278-5846. DOI: 10.1016/j.pnpbp.2017.09.013. IF 4.185.

NIKOLAIT., ŠTĚPÁNKOVÁH., KOPEČEKM., ŠULCZ., VYHNÁLEK, M., BEZDÍČEKO. The uniform data set, Czech version: normative data in older adults from an international perspective. Journal of Alzheimer´s Disease. 2018, 61(3). doi: 10.3233/JAD-170595. IF 3.476.

HROMÁDKOVÁL., KUPCIK, R., VAJRYCHOVA, M., PRIKRYL, P., CHARVATOVA, A., JANKOVICOVA, B., ŘÍPOVÁD., BILKOVA, Z., SLOVAKOVA, M. Kinase-loaded magnetic beads for sequential in vitro phosphorylation of peptides and proteins. Analyst. 2018, 143(2). doi: 10.1039/c7an01508a. IF 3.864.

OVSEPIAN S.V., O'LEARY V.B., AYVAZYAN, N.M., AL-SABI, A., NTZIACHRISTOS, V., DOLLY, J.O. Neurobilogy and therapeutic applications of neurotoxins targeting transmitter realase. Pharmacol Ther. 2018 Aug 25. doi: 10.1016/j.pharmthera.2018.08.016.  IF 11.131.

KORÁBEČNÝJ., NEPOVIMOVA, E., CIKÁNKOVÁ, T., ŠPILOVSKÁK., VASKOVA, L., MEZEIOVÁE., KUČAK., HROUDOVÁ, J. Newly developed drugs for Alzheimer’s disease in relation to energy metabolism, cholinergic and monoaminergic neurotransmission. Neuroscience. 2018, 370. doi: 10.1016/j.neuroscience.2017.06.034. IF 3.382.

UTTLL., PETRÁSEKT., SENGUL, H., SVOJANOVSKA, M., LOBELLOVA, V., VALEŠK., RADOSTOVA, D., TSENOVG., KUBOVA, H., MIKULECKA, A., SVOBODA, J., STUCHLÍKA. Chronic MK-801 Application in Adolescence and Early Adulthood: A Spatial Working Memory Deficit in Adult Long-Evans Rats But No Changes in the Hippocampal NMDA Receptor Subunits. Frontiers in Pharmacology. 2018, 9. doi: 10.3389/fphar.2018.00042. IF 3.831.

HEPNAROVA, V., KORÁBEČNÝJ., MATOUSKOVA, L., JOST, P., MUCKOVA, L., HRABINOVA, M., VYKOUKALOVA, N., KERHARTOVA, M., KUCERA, T., DOLEZAL, R., NEPOVIMOVA, E., ŠPILOVSKÁK., MEZEIOVÁE., PHAM, NL., JUN, D., STAUD, F., KAPINGD., KUČAK., SOUKUPO. The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disase. European Journal of Medicinal Chemistry. 2018, 150. doi: 10.1016/j.ejmech.2018.02.083. IF 4.816.

OLEJNÍKOVÁL., POLIDAROVÁ, L., BEHULIAK, M., SLÁDEK, M., SUMOVÁ, A. Circadian alignment in a foster mother improves the offspring's pathological phenotype. Journal of Physiology-London. May 2018. doi: 10.1113/JP275585. IF 4.540.

PETRÁSEKT., VOJTĚCHOVÁI., LOBELLOVA, V., POPELIKOVA, A., JANIKOVA, M., BROZKA, H., HOUDEK, P., SLADEK, M., SUMOVA, A., KRIŠTOFIKOVÁZ., VALEŠK., STUCHLÍKA. The McGill transgenic rat model of Alzheimer’s disease displays cognitive and motor impairments, changes in anxiety and social behavior, and altered circadian activity. Frontiers in Aging Neuroscience. 2018, 10. doi: 10.3389/fnagi.2018.00250. IF 3.582.


 


RP1 Experimental Neurobiology RP2 Social Psychiatry RP3 Applied Neurosciences and Brain Imaging RP4 Epidemiological and Clinical Research in Addictions RP5 Sleep Medicine and Chronobiology RP6 Brain Electrophysiology RP7 Diagnostics and Treatment of Mental Disorders RP8 Translational Neuroscience AD Centrum Publications Research Projects Pharmaceutical Industry-Sponsored Research Ethics Commission Postgraduate Students Conferences & Seminars Awards International Course 2015
About NIMH Czech Rep. Research Programmes Medical Care For Students Information Centre Press Contacts